top of page

Latest Publications


HKU-Pasteur Delegation Share Latest Influenza Findings at Options XIII Conference in Washington, DC
HKU-Pasteur researchers recently participated in the Options XIII Conference for the Control of Influenza, held in Washington, DC, from 30 August to 2 September 2026, following the Options XIII Mini-School on 29 August. The delegation included Malik Peiris, Sook-San Wong, Vijay Dhanasekaran, and Sophie Valkenburg, together with students Iris Li, Isaac Cheuk Long Chow, Sarah Bai, and Taoyang Wang. Organized by the International Society for Respiratory Viruses (ISRV), the confe


A single-dose amber codon carrying live attenuated vaccine elicits pan-sarbecovirus immunity and blocks SARS-CoV-2 transmission
New publication in npj Vaccines from HKU-PRP's Co-Director Professor Leo Poon's team describing an innovative approach to developing a live attenuated SARS-CoV-2 vaccine candidate. The study demonstrates a novel approach to engineering a highly attenuated yet fully immunogenic SARS-CoV-2 vaccine candidate, showing: Near-sterile immunity in mice under stringent challenge conditions Broad protection against antigenically distinct variants and even SARS-CoV Complete block of onw


Congratulations to Dr. Hogan Wai on Completing the HKU-KCL Joint PhD Programme
During his studies in the HKU-KCL Joint PhD program, Hogan conducted multidisciplinary and cross-cultural research at the HKU-Pasteur Research Pole (HKU-PRP) and the King’s College London Centre for Host-Microbiome Interactions (KCL CHMI). His PhD was focused on deciphering the role of different Staphylococcus strains in atopic dermatitis (AD): "It is well-known that the skin microbiome of AD patients is different from that of healthy individuals. There is a difference in the
bottom of page
